Aktienanalyse zu US Physical Therapy Inc (USPH)USPHUS Physical Therapy Inc

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

US Physical Therapy Inc is a good buy right now due to its current price of $85.71, which is below the analyst price target range of $90 to $98, indicating potential upside. Additionally, the company has shown a revenue growth of 8.5% year-over-year in Q2 2026, reaching $214.06 million, despite a recent earnings miss. The RSI is at 61.36, suggesting that the stock is in a healthy momentum range, and the forward P/E ratio of 27.25 indicates reasonable valuation compared to growth prospects. However, a key risk is the recent earnings miss, with EPS reported at $0.25, missing expectations by $0.53, which could impact investor sentiment.

7 analysts cover USPH: 2 rate it Buy, 5 Hold and 0 Sell. The average price target is 101.50.